Reports
Sale
Global Anti-snoring Treatment Market Share, Size, Forecast: By Device Type: Oral Appliances, Nasal Devices, Tongue Stabilizing Devices (TSDs), Position Control Devices, Expiratory Positive Airway Pressure (EPAP) Therapy Devices, Others; By Surgery Type; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Anti-Snoring Treatment Market Outlook
The global anti-snoring treatment market size was valued at USD 1.35 billion in 2023. The major drivers of the market include the sedentary lifestyle, unhealthy dietary habits, increased alcohol consumption and smoking, increasing healthcare expenditure, developing healthcare infrastructure and surge in the obese and geriatric population. The market is projected to grow at a CAGR of 7.5% during the forecast period 2024-2032 to reach a value of USD 2.60 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Lead the Market Growth of Anti-Snoring Treatment
North America holds a prominent share in the market of anti-snoring treatment, the U.S. accounting for a major market share. The region is also expected to lead the global market in anti-snoring treatment in the forecast period. There are several factors for the significant growth of this market in the region, including a surge in the obese and geriatric population, increasing awareness about sleep disorders and obstructive sleep apnea, and rising popularity of such devices and surgeries. Also, some of the major reasons which provide a comparative advantage to the region in this market include the presence of a large pool of untreated snoring population, increasing investment in R&D and the presence of major industry players in the region.
The Asia Pacific is expected to witness the highest growth in the anti-snoring treatment industry in the forecast period. Increasing healthcare expenditure and developing healthcare infrastructure will boost the market in the region. Another major reason for the market growth is the availability of comparatively low-cost products due to increased investment in R&D which enhances the demand from countries like China and India.
Anti-Snoring Treatment: Market Segmentation
Snoring occurs when air moves past relaxed tissues in the throat, causing the tissues to vibrate as we breathe. Snoring may lead to various health risks and disorders such as interrupted breathing, sleep apnea, and strain on the heart. Anti-snoring treatment helps relieve an individual from snoring. The treatment includes surgery as well as non-surgical devices. The devices include oral appliances, nasal devices, chin straps, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of device type, the market is divided into:
- Oral Appliances
- Nasal Device
- Tongue Stabilizing Devices
- Chin Straps
- Position Control Devices
- Expiratory Positive Airway Pressure (EPAP) Therapy Devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Others
Oral appliances can be further bifurcated on the basis of type into mandibular advancement devices (MAD), and tongue-retaining devices (TRDS), among others, whereas nasal devices can be distributed on the basis of type into nasal dilators (Nasal Strip), septal stimulators, among others.
The market can be classified in terms of surgery type into the following:
- Uvulopalatopharyngoplasty (UPPP)
- Laser-Assisted Uvulopalatoplasty (LAUP)
- Radiofrequency Ablation (Somnoplasty)
- Pillar Procedure
- Injection Snoreplasty/Sclerotherapy
- Palatal Stiffening Procedures
- Others
In terms of device distribution channel, the market can be divided as:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
The EMR report looks into the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Investment in R&D to Boost the Growth of the Anti-Snoring Treatment Industry
Snoring has always been prevalent, but increasing awareness about ill effects of snoring, sleep disorders and obstructive sleep apnea has fueled the demand for anti-snoring products and treatment, which has further led to rising investment in R&D in this sector. Also, factors like sedentary lifestyle, unhealthy dietary habits, increased alcohol consumption and smoking have led to the rising prevalence of sleep disorders and sleep apnea in today’s generation, which is expected to propel the anti-snoring treatment industry. Rising R&D and improved healthcare infrastructure have led to the development of various innovations and products in the sector, which is expected to enhance the growth of the anti-snoring treatment industry.
However, high cost of treatment and surgery, and limited efficacy can prove to be a barrier to the growth of the anti-snoring industry.
Key Industry Players in the Global Anti-Snoring Treatment Market
The report gives a detailed analysis of the following key players in the global anti-snoring treatment market, covering their product portfolio, new product launches, new designs and technologies, partnerships, mergers and acquisitions.
- Apnea Sciences Corporation
- GlaxoSmithKline plc
- MEDiTAS Ltd
- SomnoMed, Inc
- The Pure Sleep Company
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Device Type |
|
| Breakup by Surgery Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Anti-Snoring Treatment Market Overview
3.1 Global Anti-Snoring Treatment Market Historical Value (2017-2023)
3.2 Global Anti-Snoring Treatment Market Forecast Value (2024-2032)
4 Global Anti-Snoring Treatment Market Landscape
4.1 Global Anti-Snoring Treatment Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Anti-Snoring Treatment Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Surgery Type
4.2.3 Analysis by Distribution Channel
5 Global Anti-Snoring Treatment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Anti-Snoring Treatment Market Segmentation
6.1 Global Anti-Snoring Treatment Market by Device Type
6.1.1 Market Overview
6.1.2 Oral Appliances
6.1.2.1 Mandibular Advancement Devices (MAD)
6.1.2.2 Tongue-Retaining Devices (TRDs)
6.1.2.3 Others
6.1.3 Nasal Devices
6.1.3.1 External Nasal Dilators (Nasal Strip)
6.1.3.2 Septal Stimulators
6.1.3.3 Others
6.1.4 Tongue Stabilizing Devices (TSDs)
6.1.5 Position Control Devices
6.1.6 Expiratory Positive Airway Pressure (EPAP) Therapy Devices
6.1.7 Continuous Positive Airway Pressure (CPAP) Devices
6.1.8 Others
6.2 Global Anti-Snoring Treatment Market by Surgery Type
6.2.1 Market Overview
6.2.2 Uvulopalatopharyngoplasty
6.2.3 Laser-Assisted Uvulopalatoplasty
6.2.4 Tonsillectomy
6.2.5 Radiofrequency Palatoplasty
6.2.6 Pillar Procedure
6.2.7 Injection Snoreplasty/Sclerotherapy
6.2.8 Palatal Stiffening Procedures
6.2.9 Others
6.3 Global Anti-Snoring Treatment Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacies
6.3.3 Retail Pharmacies
6.3.4 Online
6.3.5 Others
6.4 Global Anti-Snoring Treatment Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Anti-Snoring Treatment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Anti-Snoring Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Anti-Snoring Treatment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Anti-Snoring Treatment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Anti-Snoring Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Apnea Sciences Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 GlaxoSmithKline plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 MEDiTAS Ltd
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 SomnoMed, Inc
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 The Pure Sleep Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Foundation Care
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Tomed Dr. Toussaint GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Philips Healthcare
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Airway Management Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Fisher And Paykel Healthcare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Anti-Snoring Treatment Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global anti-snoring treatment market reached a value of USD 1.35 billion in 2023.
The market is anticipated to grow at a CAGR of 7.5% during the forecast period of 2024-2032 to reach a value of USD 2.60 billion by 2032.
The major drivers of the market include the sedentary lifestyle, unhealthy dietary habits, increased alcohol consumption and smoking, increasing healthcare expenditure, developing healthcare infrastructure and surge in the obese and geriatric population.
The increasing awareness about ill effects of snoring, sleep disorders and obstructive sleep apnea, and rising investment in research and development are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
On the basis of device type, the market is divided into oral appliances, nasal device, tongue stabilizing devices, chin straps, position control devices, expiratory positive airway pressure (EPAP) therapy devices, and continuous positive airway pressure (CPAP) devices, among others.
The market can be classified in terms of surgery type into uvulopalatopharyngoplasty (UPPP), laser-assisted uvulopalatoplasty (LAUP), radiofrequency ablation (Somnoplasty), pillar procedure, injection snoreplasty/sclerotherapy, and palatal stiffening procedures, among others.
In terms of device distribution channel, the market can be divided as hospital pharmacies, retail pharmacies, and online, among others.
The major players in the industry are Apnea Sciences Corporation, GlaxoSmithKline plc, MEDiTAS Ltd, SomnoMed, Inc, and The Pure Sleep Company, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER